← Back to All US Stocks

HCMAW Stock Analysis 2026 - HCM III ACQUISITION CORP. AI Rating

HCMAW Nasdaq Blank Checks E9 CIK: 0002069856
Recently Updated • Analysis: Apr 11, 2026 • SEC Data: 2025-12-31
STRONG SELL
82% Conf
Pending
Analysis scheduled

📊 HCMAW Key Takeaways

Revenue: N/A
Net Margin: N/A
Free Cash Flow: $-355.3K
Current Ratio: 1.64x
Debt/Equity: N/A
EPS: $-0.01
AI Rating: STRONG SELL with 82% confidence

Is HCMAW a Good Investment? Thesis Analysis

Claude

HCM III is a blank check company with critically negative stockholders equity (-$12.8M), indicating technical insolvency on a balance sheet basis. The company generates no revenue, operates at a loss (-$914.2K), and maintains insufficient cash reserves ($52.5K) to fund ongoing operations or facilitate a meaningful merger/acquisition. The combination of negative equity, negative cash flow, and depleted liquidity presents an existential risk to equity holders.

Why Buy HCMAW? Key Strengths

Claude
  • + Current ratio of 1.64x suggests short-term liquidity position is adequate relative to current liabilities only
  • + Positive net income of $2.2M derived from non-operating gains provides temporary relief
  • + Total assets of $258.4M represent potential value in trust accounts or escrow

HCMAW Investment Risks to Consider

Claude
  • ! Negative stockholders equity of -$12.8M indicates balance sheet insolvency and equity dilution risk
  • ! Operating loss of -$914.2K with zero revenue confirms ongoing cash burn with no business operations
  • ! Cash position of only $52.5K is critically insufficient to fund operations or meet redemption obligations
  • ! Negative free cash flow of -$355.3K shows the company is consuming cash and cannot sustain operations
  • ! Absence of insider buying activity in 90 days suggests lack of management confidence
  • ! Typical SPAC structure poses inherent risks of failed merger and shareholder dilution

Key Metrics to Watch

Claude
  • * Cash balance and runway until insolvency
  • * Status and terms of any pending merger or business combination
  • * Quarterly operating cash flow trend
  • * Changes in stockholders equity and accumulated deficit
  • * Redemption activity and trust account depletion

HCMAW Financial Metrics

Revenue
N/A
Net Income
$2.2M
EPS (Diluted)
$-0.01
Free Cash Flow
$-355.3K
Total Assets
$258.4M
Cash Position
$52.5K

💡 AI Analyst Insight

HCM III ACQUISITION CORP. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

HCMAW Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA 0.8%
FCF Margin N/A

HCMAW vs Default Sector

How HCM III ACQUISITION CORP. compares to Default sector averages

Net Margin
HCMAW 0.0%
vs
Sector Avg 12.0%
HCMAW Sector
ROE
HCMAW 0.0%
vs
Sector Avg 15.0%
HCMAW Sector
Current Ratio
HCMAW 1.6x
vs
Sector Avg 1.8x
HCMAW Sector
Debt/Equity
HCMAW 0.0x
vs
Sector Avg 0.7x
HCMAW Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is HCMAW Overvalued or Undervalued?

Based on fundamental analysis, HCM III ACQUISITION CORP. has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
N/A
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

HCMAW Balance Sheet & Liquidity

Current Ratio
1.64x
Quick Ratio
1.64x
Debt/Equity
N/A
Debt/Assets
5.4%
Interest Coverage
N/A
Long-term Debt
N/A

HCMAW 5-Year Financial Trend & Growth Analysis

HCMAW 5-year financial data:
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: HCM III ACQUISITION CORP.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.

HCMAW Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

HCMAW Capital Allocation

Operating Cash Flow
-$355.3K
Cash generated from operations
Dividends
None
No dividend program

HCMAW SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for HCM III ACQUISITION CORP. (CIK: 0002069856)

📋 Recent SEC Filings

Date Form Document Action
Mar 30, 2026 10-K ea0281592-10k_hcm3.htm View →
Nov 14, 2025 10-Q ea0264765-10q_hcm3.htm View →
Sep 19, 2025 8-K ea0257932-8k_hcm3.htm View →
Sep 15, 2025 10-Q ea0256837-10q_hcm3.htm View →
Aug 19, 2025 8-K ea0253622-8k_hcm3.htm View →

Frequently Asked Questions about HCMAW

What is the AI rating for HCMAW?

HCM III ACQUISITION CORP. (HCMAW) has an AI rating of STRONG SELL with 82% confidence, based on fundamental analysis of SEC EDGAR filings.

What are HCMAW's key strengths?

Claude: Current ratio of 1.64x suggests short-term liquidity position is adequate relative to current liabilities only. Positive net income of $2.2M derived from non-operating gains provides temporary relief.

What are the risks of investing in HCMAW?

Claude: Negative stockholders equity of -$12.8M indicates balance sheet insolvency and equity dilution risk. Operating loss of -$914.2K with zero revenue confirms ongoing cash burn with no business operations.

What is HCMAW's revenue and growth?

HCM III ACQUISITION CORP. reported revenue of N/A.

Does HCMAW pay dividends?

HCM III ACQUISITION CORP. does not currently pay dividends.

Where can I find HCMAW SEC filings?

Official SEC filings for HCM III ACQUISITION CORP. (CIK: 0002069856) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is HCMAW's EPS?

HCM III ACQUISITION CORP. has a diluted EPS of $-0.01.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is HCMAW a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, HCM III ACQUISITION CORP. has a STRONG SELL rating with 82% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is HCMAW stock overvalued or undervalued?

Valuation metrics for HCMAW: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy HCMAW stock in 2026?

Our dual AI analysis gives HCM III ACQUISITION CORP. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is HCMAW's free cash flow?

HCM III ACQUISITION CORP.'s operating cash flow is $-355.3K, with capital expenditures of N/A.

How does HCMAW compare to other Default stocks?

Vs Default sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 1.64 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 11, 2026 | Data as of: 2025-12-31 | Powered by Claude AI